Sikiri, P., Petek, M., Rucman, R., Seiwerth, S., Grabarevi, Z., Rotkvi, I., Turkovi, B., Jagi, V., Mildner, B., & Duvnjak, M
Rather than evaluating each peptide separately, a pre-formulated blend allows researchers to investigate how the compounds interact within the same experimental model
Some researchers suggest that it inhibits an enzyme variant related to COX-2 in the brain, which produces pain and inflammation signaling molecules, thus reducing pain sensation
Read the full study: Therapeutic Potential of Pro-Angiogenic BPC157 is Associated with VEGFR2 Activation and Up-Regulation (J Mol Med 2017)
The formula is pre-mixed and distributed across 300 units of 4mg each, enabling controlled and accurate dosing for research protocols
Further investigation is needed to understand the underlying mechanisms